Inzirqo Powder, For Suspension
Product Images NDC 70954-522

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Inzirqo (NDC 70954-522). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Inzirqo (Inzirqo)

INZIRQO (hydrochlorothiazide) For Oral Suspension, USP 10 mg/mL powder for suspension label. Contains 800 mg hydrochlorothiazide per bottle, with instructions for reconstitution to make 80 mL oral suspension. Distributed by ANI Pharmaceuticals, Inc., with an NDC 70954-522-10 and a barcode on the label.*

FDA Label Image

Structure (Structure)

Chemical structure of hydrochlorothiazide showing the molecular configuration with chlorine, nitrogen, sulfur, oxygen, and hydrogen atoms clearly depicted in a ring structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.